1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broccatelli, F; Budriesi, R; Carosati, E; Chiarini, A; Cruciani, G; Ioan, P; Micucci, M; Zhorov, BS | 1 |
| Abdullaev, RIu; Gedymin, LE; Kaminskaia, GO | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Koch's Disease
| Article | Year |
|---|---|
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 2): action in other targets and antitargets.
Topics: Alzheimer Disease; Animals; Antitubercular Agents; Atherosclerosis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Resistance, Multiple; Humans; Platelet Activating Factor; Tuberculosis | 2012 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Koch's Disease
| Article | Year |
|---|---|
[Platelet activating factor in biological fluids of animals with different species-specific resistance at the stage of infective process after inoculation with mycobacterium tuberculosis].
Topics: Animals; Biomarkers; Body Fluids; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Guinea Pigs; Leukocytes; Macrophages, Alveolar; Mycobacterium tuberculosis; Platelet Activating Factor; Rabbits; Rats; Species Specificity; Tuberculosis | 1998 |